Episode 47: Clinical Conversations: Do No Harm - Alternatives to Weight Promoting Medications

September 20, 2021 00:19:10
Episode 47: Clinical Conversations: Do No Harm - Alternatives to Weight Promoting Medications
Obesity: A Disease
Episode 47: Clinical Conversations: Do No Harm - Alternatives to Weight Promoting Medications

Sep 20 2021 | 00:19:10

/

Show Notes

In this episode, Obesity medicine specialist and OMA clinical education director, Dr. Nicholas Pennings interviews Dr. Donna Ryan, highlighted speaker from Obesity Medicine 2021 – Virtual, about alternatives to weight promoting medications. Topics covered include, most commonly prescribed medications that are associated with weight gain, the variable impact of individual medications on weight, strategies that providers can use to mitigate weight effects when a patient needs to be on a medication that promotes weight gain, and resources providers can use to learn more about medications that cause weight gain and their alternatives.

You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.

Episode Guests

Nicholas Pennings, DO, FOMA, Dipl. ABOM

Donna Ryan, MD

Resources Mentioned

Do No Harm Alternatives to Weight Promoting Medications

Other Episodes

Episode

February 29, 2024 00:20:58
Episode Cover

Episode 91: Article Reviews: Obesity and Thrombosis

In this episode Co-Authors, Dr. Harold Bays and Dr. Angela Fitch, review the article Obesity, thrombosis, venous disease, lymphatic disease and lipedema: An Obesity...

Listen

Episode

September 25, 2025 00:21:28
Episode Cover

Episode 115: Clinical Conversations: Evidence Based Management of MASLD and MASH in Patients with Obesity

In this Episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings engages in a discussion with Dr. Scott Isaacs a highlighted...

Listen

Episode 0

May 17, 2023 00:16:27
Episode Cover

Episode 83: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 3 of 3

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts...

Listen